Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents
Authors:
- Antonia M. HarfordAHAntonia M. Harford
- Philip G. ZagerPZPhilip G. Zager
- Thomas B. WiltbankTWThomas B. Wiltbank
- Linda KirlinLKLinda Kirlin
- Ann Marie Della ValleAVAnn Marie Della Valle
- David B. Van WyckDWDavid B. Van Wyck
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (6) , 855-860
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy of oral iron therapy in patients receiving recombinant human erythropoietinAmerican Journal of Kidney Diseases, 1995
- Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for designStatistics in Medicine, 1992
- RACTICAL GUIDELINES FOR DRUG THERAPY IN DIALYSIS George R. Aronoff, Series Editor: Iron Dextran in Chronic Renal FailureSeminars in Dialysis, 1991
- Iron and total iron-binding capacity in serum of patients receiving iron-dextran: Kodak Ektachem methodologies, spectrophotometry, and atomic-absorption spectrometry comparedClinical Chemistry, 1990
- Short-term and long-term variability of indices related to nutritional status. I: Ca, Cu, Fe, Mg, and Zn.Clinical Chemistry, 1989
- Iron status in patients receiving erythropoietin for dialysis-associated anemiaKidney International, 1989
- Estimates of iron sufficiency in the US populationBlood, 1986
- Changes in Serum Ferritin Levels after Intravenous IronAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981
- Characteristics of Iron Dextran Utilization in ManBlood, 1969
- Metabolism of 59Fe-Dextran Complex in Human SubjectsBMJ, 1957